Australia

Delonix Bioworks Announces IND Clearance for DX-104, a Novel Engineered MenB OMV Vaccine Candidate, in China and Australia

SHANGHAI, Feb. 6, 2026 /PRNewswire/ -- Delonix Bioworks, a clinical-stage biotechnology company developing next-generation bacterial vaccines,recently announced that its Group B meningococcal (MenB) vaccine candidate, DX-104, has received Investigational New Drug (IND) clearance fromChina's Natio...

2026-02-06 20:00 4629

Kazia Therapeutics Announces Compelling Preclinical and Translational Data for Nuclear PD-L1 Degrader (NDL2)

Data identify nuclear PD-L1 as a previously unaddressed driver of immunotherapy resistance and metastatic progression SYDNEY, Jan. 30, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), an oncology-focused pharmaceutical company developing novel therapies for difficult-to-treat cancers, to...

2026-01-30 21:00 8136

Kazia Therapeutics Reports Encouraging Preliminary Clinical Responses in Ongoing Phase 1b Study of Paxalisib in Late-Stage Metastatic Triple-Negative Breast Cancer

SYDNEY, Jan. 27, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA), today provided a clinical update from its ongoing Phase1b study evaluating paxalisib in combination with pembrolizumab and chemotherapy in patients with late-stage (Stage IV), metastatic triple-negative breast cancer (TNBC)....

2026-01-27 21:00 7403

Study demonstrates effectiveness and economic value of Myriad™ in trauma and acute care surgery.

AUCKLAND, New Zealand, Jan. 21, 2026 /PRNewswire/ -- Aroa Biosurgery Limited is pleased to announce that the latest publication from its ongoing prospective study, theMyriad Augmented Soft Tissue Reconstruction Registry (MASTRR), has been published in theJournal of Trauma and Injury. MASTRR is t...

2026-01-23 03:13 4219

Hydrexia to Provide Hydrogen Application Solution to Toyota

SIDNEY, Jan. 22, 2026 /PRNewswire/ -- Hydrexia Pty Ltd, the wholly owned subsidiary of Hydrexia Holding Limited (Hydrexia), a leading hydrogen technology solution provider, announced today that it has secured an order to provide The Toyota Motor Corporation Australia Ltd (TMCA) with a number o...

2026-01-22 23:00 5037

GAC Enters Australia with AION V, M8 PHEV and EMZOOM; Launches Australian Local Strategy to Build a Benchmark Market in the South Pacific

SYDNEY, Jan. 21, 2026 /PRNewswire/ -- On November 18, 2025, GAC hosted its brand and new model launch ceremony inSydney, officially unveiling its Australia Local Strategy—"GAC: Growing Australian Confidence"—the localized implementation of the company's global "One GAC 2.0" strategy. One of the ...

2026-01-22 09:51 3865

Life's Moments App Launches Worldwide on iPhone and Android -- Turning Scattered Photos, Family Memories and Pet Moments into One Organized Family Tree

All Your Family's Memories… Finally Organized ADELAIDE, Australia, Jan. 20, 2026 /PRNewswire/ -- Life's Moments App today announced its global launch on iPhone and Android, giving families and pet owners an intuitive way to capture, store and organize photos, videos, milestones and important rec...

2026-01-20 21:07 5146

SECuRE trial to continue with no modifications to protocol following Safety Review Committee meeting

HIGHLIGHTS * Following an interim data review of the Cohort Expansion Phase (Phase II) of the SECuRE trial, the Safety Review Committee (SRC) confirms the trial will continue with no modifications to the protocol. Patient population * With the SECuRE trial continuing to recruit, a total of n...

2026-01-15 22:02 4577

Kazia Therapeutics to Participate in J.P. Morgan Healthcare Conference Week; Clinical and Translational Update Anticipated Before Month-End

SYDNEY, Jan. 8, 2026 /PRNewswire/ -- Kazia Therapeutics (NASDAQ: KZIA) today announced that its Chief Executive Officer,John Friend, MD, will be in San Francisco next week to participate in meetings during the annual J.P. Morgan Healthcare Conference week (JPM Week). During the week, Kazia will ...

2026-01-08 22:00 1313

Seeing Machines to unveil 3D Cabin Perception Mapping at CES2026

Pioneering interior sensing technology to advance automotive safety and customer experience CANBERRA, Australia, Jan. 5, 2026 /PRNewswire/ -- Seeing Machines, a global leader in vision-based monitoring technology, today announced it will unveil its next-generation 3D Cabin Perception Mapping sol...

2026-01-05 20:00 1235

Seeing Machines Announces Future Mobility Group, established to deepen integration with Autonomous Vehicle programs

CANBERRA, Australia, Jan. 2, 2026 /PRNewswire/ -- Seeing Machines, a global leader in vision-based monitoring technology, has established a dedicated  Future Mobility Group to support increasing demand from the autonomous driving sector and to advance new commercial opportunities as automated vehi...

2026-01-02 21:00 228

Co-PSMA abstract accepted for oral presentation at EAU Annual Congress 2026

SYDNEY, Dec. 24, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the acceptance of an ...

2025-12-24 22:02 2902

Kazia Therapeutics Regains Full Nasdaq Listing Compliance

Restoration of Nasdaq compliance follows $50 million institutional financing and reinforces balance-sheet strength SYDNEY, Dec. 22, 2025 /PRNewswire/ -- Kazia Therapeutics Limited ("Kazia" or the "Company") (NASDAQ: KZIA), a clinical-stage oncology company focused on developing innovative therap...

2025-12-22 21:00 5484

BUMA Australia Secures AU$740 Million Multi-Year Contract Extension with Whitehaven at Blackwater Mine Through 2030

* BUMA Australia Pty Ltd ("BUMA Australia"), a wholly owned subsidiary of PT Bukit Makmur Mandiri Utama ("BUMA"), under PT BUMA Internasional Grup Tbk ("BUMA International Group"; IDX: DOID), has secured a multi-year contract extension valued at approximately AU$740 million with Blackwater Oper...

2025-12-22 13:35 2827

Global study targets dengue as disease threatens nearly half the world's population

LISMORE, Australia, Dec. 18, 2025 /PRNewswire/ -- Thousands of dengue forecasting models have been published, but few have been tested in real public-health settings. Now, researchers from the US andAustralia are launching a field evaluation inVietnam to see whether a new early-warning platform c...

2025-12-18 21:01 3530

FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial

Highlights: * FDA has completed their review of the Neurizon NUZ-001 regimen to the HEALEY ALS Platform Trial Master Protocol * This marks the official entry of NUZ-001 as Regimen I in the HEALEY ALS Platform Trial * Next steps include obtaining single IRB approval, site initiations and cl...

2025-12-12 04:49 2058

Solace and NetComm Commercialize World's First Wirelessly Powered, Window-Mounted 5G CPE

MOUNT PEARL, NL and SYDNEY, Dec. 11, 2025 /PRNewswire/ -- Solace Power Inc. ("Solace") and NetComm Wireless ("NetComm") today announced a strategic partnership to co-develop and commercialize the world's first wirelessly powered, window-mounted outdoor 5G customer premises equipment (CPE). The p...

2025-12-11 13:00 1583

Razor Labs Launches DataMind AI™ 4.5, a Major Leap Forward in Predictive Maintenance and Fleet Management for Mining Operations

SYDNEY, Dec. 11, 2025 /PRNewswire/ -- Razor Labs (TASE:RZR) announces the launch ofDataMind AI™ 4.5, a powerful upgrade to its predictive maintenance platform designed formobile fleet management and fixed ass...

2025-12-11 05:00 1574

Kazia Therapeutics Highlights New Clinical and Translational Findings Demonstrating Paxalisib's Ability to Reinvigorate Anti-Tumor Immunity Across Multiple Advanced Breast Cancer Populations including TNBC and HER2+

First patient from TNBC trial demonstrated 76% tumor volume shrinkage with corresponding reductions in circulating tumor cells (CTC) and clusters Reinvigoration of immune system + turning cold tumors hot Preliminary ex-vivo data in HER2+ patients demonstrates immune reinvigoration and reductions...

2025-12-10 21:00 5280

Locksley Announces Oversubscribed A$17 Million Placement Lead by U.S. Investors Funding to Accelerate Execution of Locksley's U.S. Mine to Market Strategy

SAN BERNARDINO, Calif., Dec. 8, 2025 /PRNewswire/ -- Locksley Resources Limited (ASX: LKY/OTCQX: LKYRF/ADR: LKYLY) announced the successful completion of a heavily oversubscribed capital raising, securing firm commitments to raise approximatelyA$17 million via a placement of new shares at A$0.24 ...

2025-12-08 21:30 2424
12345 ... 48